Literature DB >> 27059635

Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPECT)/CT fusion imaging in hilar bile duct cancer: A retrospective study.

Tatsuaki Sumiyoshi1, Yasuo Shima2, Takehiro Okabayashi2, Akihito Kozuki2, Yasuhiro Hata3, Yoshihiro Noda3, Michihiko Kouno3, Kazuyuki Miyagawa3, Ryotaro Tokorodani3, Yuichi Saisaka2, Teppei Tokumaru2, Toshio Nakamura2, Sojiro Morita3.   

Abstract

BACKGROUND: The objective of this study was to determine the utility of Tc-99m-diethylenetriamine-penta-acetic acid-galactosyl human serum albumin ((99m)Tc-GSA) single-photon emission computed tomography (SPECT)/CT fusion imaging for posthepatectomy remnant liver function assessment in hilar bile duct cancer patients.
METHODS: Thirty hilar bile duct cancer patients who underwent major hepatectomy with extrahepatic bile duct resection were retrospectively analyzed. Indocyanine green plasma clearance rate (KICG) value and estimated KICG by (99m)Tc-GSA scintigraphy (KGSA) and volumetric and functional rates of future remnant liver by (99m)Tc-GSA SPECT/CT fusion imaging were used to evaluate preoperative whole liver function and posthepatectomy remnant liver function, respectively. Remnant (rem) KICG (= KICG × volumetric rate) and remKGSA (= KGSA × functional rate) were used to predict future remnant liver function; major hepatectomy was considered unsafe for values <0.05. The correlation of remKICG and remKGSA with posthepatectomy mortality and morbidity was determined.
RESULTS: Although remKICG and remKGSA were not significantly different (median value: 0.071 vs 0.075), functional rates of future remnant liver were significantly higher than volumetric rates (median: 0.54 vs 0.46; P < .001). Hepatectomy was considered unsafe in 17% and 0% of patients using remKICG and remKGSA, respectively. Postoperative liver failure and mortality did not occur in the patients for whom hepatectomy was considered unsafe based on remKICG. remKGSA showed a stronger correlation with postoperative prothrombin time activity than remKICG.
CONCLUSION: (99m)Tc-GSA SPECT/CT fusion imaging enables accurate assessment of future remnant liver function and suitability for hepatectomy in hilar bile duct cancer patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27059635     DOI: 10.1016/j.surg.2016.02.009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  99mTc-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value.

Authors:  Tatsuaki Sumiyoshi; Takehiro Okabayashi; Yuji Negoro; Yasuhiro Hata; Yoshihiro Noda; Kenta Sui; Jun Iwata; Manabu Matsumoto
Journal:  Jpn J Radiol       Date:  2018-06-12       Impact factor: 2.374

2.  Hepatic function assessment to predict post-hepatectomy liver failure: what can we trust? A systematic review.

Authors:  Federico Tomassini; Mariano C Giglio; Giuseppe De Simone; Roberto Montalti; Roberto I Troisi
Journal:  Updates Surg       Date:  2020-08-04

3.  A novel utility of 99mTc-GSA SPECT/CT fusion imaging: detection of inadequate portal vein embolization.

Authors:  Tatsuaki Sumiyoshi; Yasuo Shima; Takehiro Okabayashi; Yasuhiro Hata; Yoshihiro Noda; Michihiko Kouno; Yuichi Saisaka; Kenta Sui; Sojiro Morita; Yuji Negoro; Taijiro Sueda
Journal:  Jpn J Radiol       Date:  2017-10-16       Impact factor: 2.374

4.  Reliability of indocyanine green retention and clearance rates at 15 minutes calculated by dye-dilution cardiac output flowmetry in comparison to blood sampling in patients undergoing hepatic resection.

Authors:  Masahide Hiyoshi; Koichi Yano; Atsushi Nanashima; Naoya Imamura; Takeomi Hamada; Takashi Wada
Journal:  Indian J Gastroenterol       Date:  2019-12-05

Review 5.  ICG Clearance Test and 99mTc-GSA SPECT/CT Fusion Images.

Authors:  Yuji Iimuro
Journal:  Visc Med       Date:  2017-11-22

6.  99mTc-GSA scintigraphy for assessing the functional volume ratio of the future liver remnant in the routine practice of liver resection.

Authors:  Masatake Iida; Yuzo Yamamoto; Hiroki Katoh; Naoto Taniguchi; Yuki Abe; Kenta Kumagai; Hiroshi Uchinami
Journal:  Surg Open Sci       Date:  2022-01-15

7.  Predicting hepatic failure with a new diagnostic technique by preoperative liver scintigraphy and computed tomography: a pilot study in 123 patients undergoing liver resection.

Authors:  Naokazu Chiba; Motohide Shimazu; Kiminori Takano; Go Oshima; Koichi Tomita; Toru Sano; Masaaki Okihara; Yosuke Ozawa; Kosuke Hikita; Takahiro Gunji; Yuta Abe; Kiyoshi Koizumi; Shigeyuki Kawachi
Journal:  Patient Saf Surg       Date:  2017-12-18

8.  Neoadjuvant chemotherapy followed by curative-intent surgery for perihilar cholangiocarcinoma based on its anatomical resectability classification and lymph node status.

Authors:  Naohisa Kuriyama; Masanobu Usui; Kazuaki Gyoten; Aoi Hayasaki; Takehiro Fujii; Yusuke Iizawa; Hiroyuki Kato; Yasuhiro Murata; Akihiro Tanemura; Masashi Kishiwada; Hiroyuki Sakurai; Shugo Mizuno; Shuji Isaji
Journal:  BMC Cancer       Date:  2020-05-11       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.